ABCG2 and colorectal carcinoma: One study demonstrated that anticancer drugs activate the IRE1α–XBP1 axis and induce the expression of ABCB1, ABCC1 and ABCG2, and targeting this pathway overcomes the drug resistance of CRC cells [38].